Zymeworks ZYME Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Zymeworks’s reported figures.
Based on trailing twelve months.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's return on equity?
- Zymeworks (ZYME) reported return on equity of -42% in Q1 2026.
- How has Zymeworks's return on equity changed year-over-year?
- Zymeworks's return on equity decreased by 41.0% year-over-year, from -29.8% to -42%.
- What is the long-term trend for Zymeworks's return on equity?
- Over 5 years (2020 to 2025), Zymeworks's return on equity has grown at a -13.5% compound annual growth rate (CAGR), from -55.1% to -26.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.